Ginkgo Bioworks Holdings (DNA) Non Operating Investment Income (2020 - 2026)

Ginkgo Bioworks Holdings (DNA) has 7 years of Non Operating Investment Income data on file, last reported at -$1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Investment Income rose 67.13% year-over-year to -$1.2 million; the trailing twelve-month figure through Mar 2026 stood at -$13.9 million (up 53.52% YoY), and the FY2025 full-year result was -$16.4 million, up 43.07% from the prior year.
• Non Operating Investment Income for Q1 2026 stood at -$1.2 million, up from -$16.2 million in the prior quarter.
• Across five years, Non Operating Investment Income topped out at $3.7 million in Q3 2025 and bottomed at -$38.7 million in Q2 2022.
• The 5-year median for Non Operating Investment Income is -$6.4 million (2023), against an average of -$9.1 million.
• The widest annual swing landed in 2023, when Non Operating Investment Income sank 1966.21%; it then jumped 153.3% in 2025.
• A 5-year view of Non Operating Investment Income shows it stood at -$13.4 million in 2022, then grew by 25.03% to -$10.0 million in 2023, then declined by 25.3% to -$12.5 million in 2024, then decreased by 28.92% to -$16.2 million in 2025, then soared by 92.49% to -$1.2 million in 2026.
• The last three Non Operating Investment Income figures came in at -$1.2 million (Q1 2026), -$16.2 million (Q4 2025), and $3.7 million (Q3 2025), per Business Quant data.

Peer Comparison